期刊文献+

综合序贯疗法治疗Kasabach-Merritt综合征 被引量:12

Combined and sequential therapy for Kasabach-Merritt syndrome
原文传递
导出
摘要 目的分析Kasabach—Merritt综合征(KMS)的治疗方法。方法对2005--2009年采用综合序贯疗法治疗的51例KMS患儿的临床和随访资料进行回顾性分析。其中男27例,女24例;年龄2d至2.5岁,中位年龄1.8个月。病变部位:颌面部20例,躯干4例,上肢11例,下肢16例。结果51例KMS患儿中,3例(右颌面、左前臂、右大腿部各1例)因血管瘤意外破溃行急诊血管瘤切除手术,全部痊愈;余48例首先接受激素联合尿素局部注射治疗,其中激素敏感12例,有效15例,无效21例;对激素无效的21例患儿序贯给予丙种球蛋白治疗,敏感5例,有效7例,无效9例。单纯药物加局部尿素治疗共14例,11例痊愈,3例有效;血小板计数4~7d恢复到正常的4例,8~14d恢复的5例,15~28d恢复的2例,超过28d恢复的3例;瘤体6—12个月消失的6例,13—24个月消失的8例。对颌面部血管瘤行颈外动脉结扎置管介入治疗,共19例,全部痊愈;血小板计数术后4~7d恢复到正常的13例,8~14d恢复的6例;瘤体6~12个月消失的12例,13~24个月消失的7例。药物治疗反应无效或1腐隋反复的躯干、四肢血管瘤行择期血管瘤切除手术,共15例,痊愈14例,死亡1例。所有血管瘤切除手术中,行病变完全切除者10例,术后1—3dm小板恢复正常;病变大部切除者8例,术后8—14d血小板恢复正常。结论综合序贯疗法治疗KMS效果确切,治愈率高,无明显不良反应。 Objective To review and summarize the clinical characteristics and therapeutic approaches of Kasabach-Merritt syndrome ( KMS). Methods The combined and sequential therapy was used to for 51 KMS infants between 2005 and 2009. And all cases were retrospectively analyzed. There were 27 males and 24 females with a median age of 1.8 months ( range : 2 days to 2.5 years). Among them, lesions were located in maxillofacial ( n = 20) , truck ( n = 4 ), upper extremities ( n = 11 ) and lower extremities (n = 16). Results Among them, 47 of 51 patients were cured, 3 cases were effectively treated and only 1 patient died of multiple organ failure post-operation. Of the 51 cases, emergency surgery was given in 3 cases while other 48 cases were initially treated with methylprednisolone. The responses were varied : excellent and rapid improvement ( n = 12) ; moderate response ( n = 15 ) and total failure ( n = 21 ). Immunoglobulin was used a second-line therapy for those (n = 21 ) unresponsive to steroid, with sensitive response( n = 5 ), effective response ( n = 7 ) and invalid response ( n = 9 ) respectively. And adjunct carbonyldiamide therapy was combined. Conservative treatment was tried in 14 patients. Then 11 curative cases and 3 effective cases were observed. The thrombocyte count in 4 cases returned to normal within 4 - 7 days, 5 cases within 8 -14 days, and 2 cases within 15 -28 days. In the remaining 3 cases, it normalized more than 28 days. The hemangiomas in 6 cases disappeared completely in 6 - 12 months and 8 cases disappeared in 13 - 24 months. 19 patients were treated with the ligation of external carotid artery, the insertion of a tube inside the lesion and the injections of carbonyldiamide and methylprednisolone. The platelet counts of 13 cases increased to normal in 4 -7 days of the treatment, and 6 cases in 8 - 14 days. The tumors of 12 cases disappeared within 6 - 12 months, and 7 cases within 13 - 24 months. Combined surgical resection including emergency operation (n =3 ) and selective operation (n = 15) was performed in 18 patients. And all cases except for one were cured. The platelet counts of that the hemangiomas of 10 cases were excised surgically completely increased rapidly and reached the normal range in post-operative 1 - 3 days. The counts of 8 cases after subtotal resection increased to normal within 8 - 14 days. Conclusion A stepwise multimodal approach is recommended for the treatment of KMS. With a higher curative rate, it has minimal side effects.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第36期2538-2541,共4页 National Medical Journal of China
基金 河南省医学科技攻关项目(200803114)
关键词 血管瘤 血小板减少 治疗 Kasabach—Merritt综合征 Hemangioma Thrombocytopenia Therapy Kasabach-Merritte syndrome
  • 相关文献

参考文献9

  • 1Maguiness S,Guentber LKasabach-Merritt syndrome.J Cutan Med Surg,2002,6:335-339.
  • 2Frevel T,Rabe H,Uckert F,et al.Giant cavernous haemangioma with Kasabach-Merritt syndrome:a case report and review.Eur J Pediatr,2002,161:243-246.
  • 3Wananukul S,Nuchprayoon I,Seksarn P.Treatment of KasabachMerrittsyndrome:astepwiseregimenofprednisolone,dipyridamole,and interferon.Int J Dermatol,2003,42:741-748.
  • 4Abass K,Saad H,Kherala M,et al.Successful treatment of kasabach-merritt syndrome with vincristine and surgery:a case report and review of literature.Cases J,2008,1:9.
  • 5Hesselmann S,Micke O,Marquardt T,et al.Case report:Kasabach-Merritt syndrome:a review of the therapeutic option and a casereportof successfultreatmentwithradiotherapyand interferon alpha.Br J Radiol,2002,75:180-184.
  • 6Kim T,Roh MR,Cho S,et al.Kasabach-merritt syndrome arising fromtuftedangiomasuccessfullytreatedwithsystemic corticosteroid.Ann Dermatol,2010,22:426-430.
  • 7董长宪,马玉春,李恭才,张连仲,郭会斌.尿素介入治疗面颌部重症海绵状血管瘤[J].中华整形外科杂志,2004,20(4):316-317. 被引量:20
  • 8董长宪,武宇红,马玉春,张连仲,刘大看,肖莉,雷红召.尿素与甲基强的松龙联合介入治疗颌面部重症血管瘤伴血小板减少[J].中华小儿外科杂志,2009,30(1):17-19. 被引量:7
  • 9PhillipsWG,MarsdenJR.Kasabaeh-Merrittsyndrome exacerbated by platelet transfusion.J R Soc Med,1993,86:231-232.

二级参考文献14

  • 1董长宪,马玉春,李恭才,张连仲,郭会斌.尿素介入治疗面颌部重症海绵状血管瘤[J].中华整形外科杂志,2004,20(4):316-317. 被引量:20
  • 2董长宪,马玉春,李振鲁,李恭才,郭会斌.尿素介入治疗面部毛细血管瘤[J].中华皮肤科杂志,2003,36(12):751-751. 被引量:6
  • 3郑家伟,秦中平,张志愿,周国瑜.口服皮质激素治疗婴幼儿口腔颌面部血管瘤[J].中国口腔颌面外科杂志,2006,4(3):228-232. 被引量:52
  • 4李晓瑜,余慕雪,陈东平,庄思齐,陈玮琪,刘美娜.新生儿Kasabach-Merritt综合征5例报道并文献复习[J].中国优生与遗传杂志,2006,14(6):87-88. 被引量:5
  • 5Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med,1999,341 : 173-181.
  • 6Maguiness S, Guentber L. Kasabach-Merritt syndrome. J Cutan Med Surg, 2002,6 : 335-339.
  • 7Frevel T,Rabe H, Ckert F, et al. Giant cavernous haemangioma with Kasabach-Merritt syndrome : a case report and review. Eur J Pediatr, 2002,161 : 243-246.
  • 8MuIliken JB, Glowaeki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg, 1982,69 : 412-420.
  • 9Larsen EC,Zinkham WH, Eggleston JC, et al. Kasabach - Merritt syndrome: therapeutic consideration. Pediatrics, 1987, 79: 971-980.
  • 10Hesselmann S, Micke O, Marquardt T, et al. Case report: Kasabach-Merritt syndrome: a review of the therapeutic option and a case report of successful treatment with radiotherapy and interferon alphs, Br J Radiol, 2002,75: 180-184.

共引文献22

同被引文献66

  • 1董长宪,马玉春,李恭才,张连仲,郭会斌.尿素介入治疗面颌部重症海绵状血管瘤[J].中华整形外科杂志,2004,20(4):316-317. 被引量:20
  • 2汤宏峰,周媛媛,顾伟忠,李民驹.卡波西形血管内皮瘤临床病理特征[J].中华外科杂志,2004,42(18):1132-1135. 被引量:14
  • 3高凤鸣,高建超.尿素治疗小鼠可移植性肝癌疗效观察和作用机制的研究[J].中华医学杂志,1989,69(9):499-502. 被引量:2
  • 4王坚,朱雄增.软组织肿瘤病理学[M].北京:人民卫生出版社.2008:81-84,124-126.
  • 5Kwok-Williams M, Perez Z, Squire R, et al. Radiotherapy for life- threatening mediastinal haemangioma with Kasabach-Merritt Syn- drome. Pediatr Blood Cancer,2007,49(5 ) :739-744.
  • 6Yoon HS,Lee JH, Moon HN, et al. Successful treatment of retroper- itoneal infantile hemangioendothelioma with Kasabach-Merritt syn- drome using steroid, a-interferon, and vincristine. J Pediatr Hematol Onco1,2009,31 ( 12 ) :952-954.
  • 7Hauer J,Graubner U, Konstantopoulos N, et al. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach- Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer, 2007,49(6) :852-854.
  • 8Hesselmann S, Micke O, Marquardt T, et al. Case report: Kasabach- Merritt syndrome: a review of the therapeutic option and a case report of successful treatment with radiotherapy and interferon alpha. Br J Radio1,2002,75 (890) : 180-184.
  • 9Kim T, Roh MR, Cho S, et al. Kasabach-Merritt syndrome arising from tufted angioma successfully treated with systemic corticoste- roid. Ann Dermatol,2010,22(4) :426-430.
  • 10Michaud AP,Bauman NM, Burke DK, et al. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryn- goscope,2004,114 (7) : 1231-1236.

引证文献12

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部